Cardiff Oncology Inc (CRDF)
3.29
-0.17
(-4.91%)
USD |
NASDAQ |
May 07, 15:22
Cardiff Oncology Total Assets (Quarterly): 74.04M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 74.04M |
| December 31, 2023 | 81.64M |
| September 30, 2023 | 88.45M |
| June 30, 2023 | 97.46M |
| March 31, 2023 | 106.55M |
| December 31, 2022 | 116.19M |
| September 30, 2022 | 123.63M |
| June 30, 2022 | 131.26M |
| March 31, 2022 | 139.20M |
| December 31, 2021 | 149.54M |
| September 30, 2021 | 141.31M |
| June 30, 2021 | 143.73M |
| March 31, 2021 | 129.57M |
| December 31, 2020 | 134.73M |
| September 30, 2020 | 39.45M |
| June 30, 2020 | 30.13M |
| March 31, 2020 | 11.82M |
| December 31, 2019 | 13.09M |
| September 30, 2019 | 11.92M |
| June 30, 2019 | 13.87M |
| March 31, 2019 | 14.53M |
| December 31, 2018 | 14.17M |
| September 30, 2018 | 17.92M |
| June 30, 2018 | 21.77M |
| March 31, 2018 | 10.41M |
| Date | Value |
|---|---|
| December 31, 2017 | 12.28M |
| September 30, 2017 | 12.22M |
| June 30, 2017 | 12.56M |
| March 31, 2017 | 33.93M |
| December 31, 2016 | 43.95M |
| September 30, 2016 | 53.00M |
| June 30, 2016 | 56.72M |
| March 31, 2016 | 66.01M |
| December 31, 2015 | 71.45M |
| September 30, 2015 | 77.02M |
| June 30, 2015 | 43.64M |
| March 31, 2015 | 45.83M |
| December 31, 2014 | 28.90M |
| September 30, 2014 | 32.76M |
| June 30, 2014 | 36.19M |
| March 31, 2014 | 24.46M |
| December 31, 2013 | 27.16M |
| September 30, 2013 | 29.15M |
| June 30, 2013 | 9.625M |
| March 31, 2013 | 10.20M |
| December 31, 2012 | 11.66M |
| September 30, 2012 | 8.571M |
| June 30, 2012 | 9.952M |
| March 31, 2012 | 1.182M |
| December 31, 2011 | 1.039M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.82M
Minimum
Mar 2020
149.54M
Maximum
Dec 2021
88.88M
Average
102.00M
Median
Total Assets (Quarterly) Benchmarks
| BioVie Inc | 21.49M |
| Perspective Therapeutics Inc | 97.89M |
| Biolase Inc | 35.10M |
| Tenon Medical Inc | 6.345M |
| Adial Pharmaceuticals Inc | 4.737M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.14M |
| Shareholders Equity (Quarterly) | 60.89M |
| Current Ratio | 5.910 |